# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-24-004927
Filing Date
2024-04-10
Accepted
2024-04-10 16:15:25
Documents
56
Period of Report
2024-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | apre-20240410x8k.htm iXBRL | 8-K | 39952
2 | EX-99.1 | apre-20240410xex99d1.htm | EX-99.1 | 61054
3 | EX-99.2 | apre-20240410xex99d2.htm | EX-99.2 | 60962
4 | GRAPHIC | apre-20240410xex99d1001.jpg | GRAPHIC | 8473
5 | GRAPHIC | apre-20240410xex99d2g001.jpg | GRAPHIC | 105869
6 | GRAPHIC | apre-20240410xex99d2g002.jpg | GRAPHIC | 335137
7 | GRAPHIC | apre-20240410xex99d2g003.jpg | GRAPHIC | 176030
8 | GRAPHIC | apre-20240410xex99d2g004.jpg | GRAPHIC | 121116
9 | GRAPHIC | apre-20240410xex99d2g005.jpg | GRAPHIC | 140117
10 | GRAPHIC | apre-20240410xex99d2g006.jpg | GRAPHIC | 180069
11 | GRAPHIC | apre-20240410xex99d2g007.jpg | GRAPHIC | 56499
12 | GRAPHIC | apre-20240410xex99d2g008.jpg | GRAPHIC | 148628
13 | GRAPHIC | apre-20240410xex99d2g009.jpg | GRAPHIC | 175338
14 | GRAPHIC | apre-20240410xex99d2g010.jpg | GRAPHIC | 108778
15 | GRAPHIC | apre-20240410xex99d2g011.jpg | GRAPHIC | 145554
16 | GRAPHIC | apre-20240410xex99d2g012.jpg | GRAPHIC | 135501
17 | GRAPHIC | apre-20240410xex99d2g013.jpg | GRAPHIC | 118212
18 | GRAPHIC | apre-20240410xex99d2g014.jpg | GRAPHIC | 57503
19 | GRAPHIC | apre-20240410xex99d2g015.jpg | GRAPHIC | 175774
20 | GRAPHIC | apre-20240410xex99d2g016.jpg | GRAPHIC | 135964
21 | GRAPHIC | apre-20240410xex99d2g017.jpg | GRAPHIC | 143057
22 | GRAPHIC | apre-20240410xex99d2g018.jpg | GRAPHIC | 59125
23 | GRAPHIC | apre-20240410xex99d2g019.jpg | GRAPHIC | 179041
24 | GRAPHIC | apre-20240410xex99d2g020.jpg | GRAPHIC | 176838
25 | GRAPHIC | apre-20240410xex99d2g021.jpg | GRAPHIC | 141034
26 | GRAPHIC | apre-20240410xex99d2g022.jpg | GRAPHIC | 163907
27 | GRAPHIC | apre-20240410xex99d2g023.jpg | GRAPHIC | 92006
28 | GRAPHIC | apre-20240410xex99d2g024.jpg | GRAPHIC | 163160
29 | GRAPHIC | apre-20240410xex99d2g025.jpg | GRAPHIC | 94193
30 | GRAPHIC | apre-20240410xex99d2g026.jpg | GRAPHIC | 148082
31 | GRAPHIC | apre-20240410xex99d2g027.jpg | GRAPHIC | 58616
32 | GRAPHIC | apre-20240410xex99d2g028.jpg | GRAPHIC | 167517
33 | GRAPHIC | apre-20240410xex99d2g029.jpg | GRAPHIC | 91294
34 | GRAPHIC | apre-20240410xex99d2g030.jpg | GRAPHIC | 61143
35 | GRAPHIC | apre-20240410xex99d2g031.jpg | GRAPHIC | 160600
36 | GRAPHIC | apre-20240410xex99d2g032.jpg | GRAPHIC | 167115
37 | GRAPHIC | apre-20240410xex99d2g033.jpg | GRAPHIC | 140410
38 | GRAPHIC | apre-20240410xex99d2g034.jpg | GRAPHIC | 117193
39 | GRAPHIC | apre-20240410xex99d2g035.jpg | GRAPHIC | 135472
40 | GRAPHIC | apre-20240410xex99d2g036.jpg | GRAPHIC | 78612
41 | GRAPHIC | apre-20240410xex99d2g037.jpg | GRAPHIC | 161474
42 | GRAPHIC | apre-20240410xex99d2g038.jpg | GRAPHIC | 161239
43 | GRAPHIC | apre-20240410xex99d2g039.jpg | GRAPHIC | 152821
| Complete submission text file | 0001558370-24-004927.txt |  | 7675887

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
44 | EX-101.SCH | apre-20240410.xsd | EX-101.SCH | 3995
45 | EX-101.DEF | apre-20240410_def.xml | EX-101.DEF | 2844
46 | EX-101.LAB | apre-20240410_lab.xml | EX-101.LAB | 17245
47 | EX-101.PRE | apre-20240410_pre.xml | EX-101.PRE | 11355
59 | EXTRACTED XBRL INSTANCE DOCUMENT | apre-20240410x8k_htm.xml | XML | 4859

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24835959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)